Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry

Physiological Genomics

Volumn 40, Issue 3, 2010, Pages 208-215

  Collins, Lisamarie A ^a   Mirza, Shama P ^a   Kissebah, Ahmed H ^a   Olivier, Michael ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Fast protein liquid chromatography; High density lipoprotein; Liquid chromatography; Proteomics

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEOMICS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIPOPROTEINS; TANDEM MASS SPECTROMETRY;

EID: 76549121693     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00136.2009     Document Type: Article

References (30)

1. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1: 947-955, 2002.
2. Blatter Garin MC, Moren X, James RW. Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I. J Lipid Res 47: 515-520, 2006.
3. Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86: 19L-22L, 2000.
4. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 76: 4-12, 1984.
5. Chetiveaux M, Nazih H, Ferchaud-Roucher V, Lambert G, Zair Y, Masson M, Ouguerram K, Bouhours D, Krempf M. The differential apoA-I enrichment of prebeta1 and alphaHDL is detectable by gel filtration separation. J Lipid Res 43: 1986-1993, 2002.
6. Cheung MC, Wolf AC. Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations. J Lipid Res 29: 15-25, 1988.
7. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 261: 9644-9651, 1986.
8. Echan L, Hsin-Yao T, Ali-Khan N, KiBeom L, Speicher DW. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5: 3292-3303, 2005.
9. Eng JK, McCormack AL, Yates JR 3rd. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5: 976-989, 1994.
10. Gundry R, Qin F, Jelinek CA, Van Eyk JE, Cotter RJ. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl 1: 73-88, 2007.
11. Halligan BD, Slyper RY, Twigger SN, Hicks W, Olivier M, Greene AS. ZoomQuant: an application for the quantitation of stable isotope labeled peptides. J Am Soc Mass Spectrom 16: 302-306, 2005.
12. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
13. Heller M, Stalder D, Schlappritzi E, Hayn G, Matter U, Haeberli A. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins. Proteomics 5: 2619-2630, 2005.
14. Henderson R, Wasan K, Leon C. Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma. Lipids Health Dis 8: 27, 2009.
15. Hoofnagle AN, Heinecke JW. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res 50: 1967-1975, 2009.
16. Innis-Whitehouse W, Li X, Brown WV, Le NA. An efficient chromatographic system for lipoprotein fractionation using whole plasma. J Lipid Res 39: 679-690, 1998.
17. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5: 1431-1445, 2005.
18. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: Mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5: 551-565, 2005.
19. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392, 2002.
20. Kunitake ST, Carilli CT, Lau K, Protter AA, Naya-Vigne J, Kane JP. Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption. Biochemistry 33: 1988-1993, 1994.
21. Kunitake ST, Kane JP. Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res 23: 936-940, 1982.
22. Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 4193-4201, 2004.
23. Mirza SP, Halligan BD, Greene AS, Olivier M. Improved method for the analysis of membrane proteins by mass spectrometry. Physiol Genomics 30: 89-94, 2007.
24. Nanjee MN, Brinton EA. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography. Clin Chem 46: 207-223, 2000.
25. Ordovas JM, Osgood D. Preparative isolation of plasma lipoproteins using fast protein liquid chromatography (FPLC). Methods Mol Biol 110: 105-111, 1998.
26. Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC. Proteomic analysis of high-density lipoprotein. Proteomics 6: 721-730, 2006.
27. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, Anantharamaiah GM. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33: 141-166, 1992.
28. Stahlman M, Davidsson P, Kanmert I, Rosengren B, Boren J, Fagerberg B, Camejo G. Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J Lipid Res 49: 481-490, 2008.
29. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117: 746 -756, 2007.
30. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4: 409-418, 2005.